Tsukasa Okiyoneda

7PUBLICATIONS
18CO-AUTHORS
Cancer therapy (excl. chemotherapy and radiation therapy)Proteomics and intermolecular interactions (excl. medical proteomics)BioremediationSurface water quality processes and contaminated sediment assessmentCancer genetics
Featured researcher

Get your video featured.

JoVEPublish with JoVE
Journal

Publications (7)

|Feb 21, 2026
RFFL-mediated protein quality control limits functional rescue of TRID-CFTR modulator combination therapy for cystic fibrosis nonsense mutations.

Hazuki Tateishi, Yukako Doi, Yuka Kamada

|May 09, 2024
HERC3 facilitates ERAD of select membrane proteins by recognizing membrane-spanning domains.

Yuka Kamada, Yuko Ohnishi, Chikako Nakashima

|Dec 09, 2023
UBE3C Facilitates the ER-Associated and Peripheral Degradation of Misfolded CFTR.

Yuka Kamada, Hazuki Tateishi, Uta Nakayamada

|May 04, 2023
The multiple ubiquitination mechanisms in CFTR peripheral quality control.

Shogo Taniguchi, Ryosuke Fukuda, Tsukasa Okiyoneda

|Feb 11, 2023
The COPD-Associated Polymorphism Impairs the CFTR Function to Suppress Excessive IL-8 Production upon Environmental Pathogen Exposure.

Daichi Hinata, Ryosuke Fukuda, Tsukasa Okiyoneda

Pageof 2